Logo image of CRBG

COREBRIDGE FINANCIAL INC (CRBG) Stock Fundamental Analysis

NYSE:CRBG - US21871X1090 - Common Stock

34.645 USD
-0.32 (-0.93%)
Last: 8/25/2025, 2:32:24 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CRBG. CRBG was compared to 100 industry peers in the Financial Services industry. Both the profitability and financial health of CRBG have multiple concerns. CRBG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CRBG was profitable.
CRBG had a positive operating cash flow in the past year.
CRBG had positive earnings in each of the past 5 years.
In the past 5 years CRBG always reported a positive cash flow from operatings.
CRBG Yearly Net Income VS EBIT VS OCF VS FCFCRBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

CRBG's Return On Assets of -0.08% is on the low side compared to the rest of the industry. CRBG is outperformed by 75.00% of its industry peers.
Looking at the Return On Equity, with a value of -2.74%, CRBG is doing worse than 80.00% of the companies in the same industry.
CRBG's Return On Invested Capital of 0.20% is on the low side compared to the rest of the industry. CRBG is outperformed by 70.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRBG is significantly below the industry average of 7.81%.
Industry RankSector Rank
ROA -0.08%
ROE -2.74%
ROIC 0.2%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
CRBG Yearly ROA, ROE, ROICCRBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

CRBG's Profit Margin has improved in the last couple of years.
CRBG's Operating Margin of 7.02% is on the low side compared to the rest of the industry. CRBG is outperformed by 63.00% of its industry peers.
CRBG's Operating Margin has improved in the last couple of years.
The Profit Margin and Gross Margin are not available for CRBG so they could not be analyzed.
Industry RankSector Rank
OM 7.02%
PM (TTM) N/A
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBG Yearly Profit, Operating, Gross MarginsCRBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRBG is destroying value.
CRBG has less shares outstanding than it did 1 year ago.
CRBG has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CRBG is higher compared to a year ago.
CRBG Yearly Shares OutstandingCRBG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBG Yearly Total Debt VS Total AssetsCRBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

CRBG has a debt to FCF ratio of 6.76. This is a slightly negative value and a sign of low solvency as CRBG would need 6.76 years to pay back of all of its debts.
CRBG's Debt to FCF ratio of 6.76 is fine compared to the rest of the industry. CRBG outperforms 62.00% of its industry peers.
CRBG has a Debt/Equity ratio of 0.92. This is a neutral value indicating CRBG is somewhat dependend on debt financing.
CRBG has a Debt to Equity ratio of 0.92. This is comparable to the rest of the industry: CRBG outperforms 47.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.76
Altman-Z N/A
ROIC/WACC0.03
WACC7.64%
CRBG Yearly LT Debt VS Equity VS FCFCRBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBG Yearly Current Assets VS Current LiabilitesCRBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

CRBG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.75%, which is quite good.
Measured over the past years, CRBG shows a very strong growth in Earnings Per Share. The EPS has been growing by 115.54% on average per year.
The Revenue for CRBG has decreased by -16.47% in the past year. This is quite bad
CRBG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.01% yearly.
EPS 1Y (TTM)18.75%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%20.35%
Revenue 1Y (TTM)-16.47%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%5.84%

3.2 Future

CRBG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.21% yearly.
Based on estimates for the next years, CRBG will show a small growth in Revenue. The Revenue will grow by 3.39% on average per year.
EPS Next Y4.1%
EPS Next 2Y8.75%
EPS Next 3Y11.33%
EPS Next 5Y10.21%
Revenue Next Year-6.84%
Revenue Next 2Y-1.83%
Revenue Next 3Y-0.48%
Revenue Next 5Y3.39%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBG Yearly Revenue VS EstimatesCRBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CRBG Yearly EPS VS EstimatesCRBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.75 indicates a rather cheap valuation of CRBG.
Compared to the rest of the industry, the Price/Earnings ratio of CRBG indicates a rather cheap valuation: CRBG is cheaper than 88.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.24. CRBG is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 6.05, the valuation of CRBG can be described as very cheap.
Based on the Price/Forward Earnings ratio, CRBG is valued cheaper than 86.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.81, CRBG is valued rather cheaply.
Industry RankSector Rank
PE 6.75
Fwd PE 6.05
CRBG Price Earnings VS Forward Price EarningsCRBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRBG.
76.00% of the companies in the same industry are more expensive than CRBG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.12
EV/EBITDA 22.76
CRBG Per share dataCRBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.65
PEG (5Y)0.06
EPS Next 2Y8.75%
EPS Next 3Y11.33%

3

5. Dividend

5.1 Amount

CRBG has a Yearly Dividend Yield of 2.81%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.27, CRBG pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, CRBG pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

CRBG has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRBG Yearly Dividends per shareCRBG Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

The earnings of CRBG are negative and hence is the payout ratio. CRBG will probably not be able to sustain this dividend level.
DP-156.08%
EPS Next 2Y8.75%
EPS Next 3Y11.33%
CRBG Yearly Income VS Free CF VS DividendCRBG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

COREBRIDGE FINANCIAL INC

NYSE:CRBG (8/25/2025, 2:32:24 PM)

34.645

-0.32 (-0.93%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners92.72%
Inst Owner Change-8.43%
Ins Owners0.34%
Ins Owner Change-20.88%
Market Cap18.66B
Analysts79.05
Price Target42.08 (21.46%)
Short Float %1.08%
Short Ratio1.38
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP-156.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-16 2025-09-16 (0.24)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.55%
Min EPS beat(2)-0.44%
Max EPS beat(2)15.55%
EPS beat(4)3
Avg EPS beat(4)7.91%
Min EPS beat(4)-0.44%
Max EPS beat(4)15.87%
EPS beat(8)6
Avg EPS beat(8)4.91%
EPS beat(12)10
Avg EPS beat(12)8.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.67%
Min Revenue beat(2)-11.92%
Max Revenue beat(2)-11.42%
Revenue beat(4)0
Avg Revenue beat(4)-14.95%
Min Revenue beat(4)-21.6%
Max Revenue beat(4)-11.42%
Revenue beat(8)3
Avg Revenue beat(8)-7.82%
Revenue beat(12)6
Avg Revenue beat(12)0.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.7%
PT rev (3m)17.58%
EPS NQ rev (1m)-2.91%
EPS NQ rev (3m)-10.18%
EPS NY rev (1m)1.75%
EPS NY rev (3m)-0.88%
Revenue NQ rev (1m)-4.89%
Revenue NQ rev (3m)-12.4%
Revenue NY rev (1m)-5.77%
Revenue NY rev (3m)-7.82%
Valuation
Industry RankSector Rank
PE 6.75
Fwd PE 6.05
P/S 1.27
P/FCF 11.12
P/OCF 11.12
P/B 1.52
P/tB 1.52
EV/EBITDA 22.76
EPS(TTM)5.13
EY14.81%
EPS(NY)5.72
Fwd EY16.52%
FCF(TTM)3.12
FCFY8.99%
OCF(TTM)3.12
OCFY8.99%
SpS27.22
BVpS22.85
TBVpS22.85
PEG (NY)1.65
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA -0.08%
ROE -2.74%
ROCE 0.26%
ROIC 0.2%
ROICexc 0.2%
ROICexgc 0.3%
OM 7.02%
PM (TTM) N/A
GM N/A
FCFM 11.45%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
ROICexc(3y)1.09%
ROICexc(5y)0.99%
ROICexgc(3y)1.62%
ROICexgc(5y)1.5%
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexcg growth 3Y-24.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y-23.75%
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.76
Debt/EBITDA 8.67
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.78
Cash Conversion 128.19%
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.64%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)18.75%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%20.35%
EPS Next Y4.1%
EPS Next 2Y8.75%
EPS Next 3Y11.33%
EPS Next 5Y10.21%
Revenue 1Y (TTM)-16.47%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%5.84%
Revenue Next Year-6.84%
Revenue Next 2Y-1.83%
Revenue Next 3Y-0.48%
Revenue Next 5Y3.39%
EBIT growth 1Y-41.6%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next Year-7.21%
EBIT Next 3Y0.32%
EBIT Next 5YN/A
FCF growth 1Y-55.04%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-55.04%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%